Schedule II - Valuation and Qualifying Accounts
 12 Months Ended
Dec. 31, 2021
Notes to Financial Statements  
SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]
GEOVAX LABS, INC.
SCHEDULE II
–
VALUATION AND QUALIFYING ACCOUNTS
 
For the Years Ended
December 31, 2021
and
2020
 
           
Additions (Reductions)
                  
Description
  
Balance at
Beginning
Of Period
    
Charged to
Costs and
Expenses
    
Charged to
Other
Accounts
    
Deductions
    
Balance at
End
Of Period
  
Reserve Deducted in the Balance Sheet From the Asset to Which it Applies:
                                        
                                         
Allowance for Deferred Tax Assets
                                        
Year ended December 31, 2021
   $
15,975,667
     $
4,208,790
     $
-0-
     $
-0-
     $
20,184,457
  
Year ended December 31, 2020
   $
18,787,230
     $
(2,811,563
 )   $
-0-
     $
-0-
     $
15,975,667